RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AgeX Therapeutics - Stock

AgeX Therapeutics Dividend 2024

AgeX Therapeutics Dividend

0 USD

AgeX Therapeutics Dividend yield

Ticker

SER

ISIN

US00848H1086

WKN

A2N8PC

How much dividend does AgeX Therapeutics 2024 pay?

According to the latest status from June 2024, AgeX Therapeutics paid a total of 0 USD per share in dividends within the last 12 months. With the current AgeX Therapeutics price of 9.58 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical AgeX Therapeutics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the AgeX Therapeutics Dividend Safe?

AgeX Therapeutics has been increasing the dividend for 0 years.

Over the past 8 years, AgeX Therapeutics has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding AgeX Therapeutics's Dividend Distributions

AgeX Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining AgeX Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

AgeX Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in AgeX Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

AgeX Therapeutics Aktienanalyse

What does AgeX Therapeutics do?

AgeX Therapeutics Inc is an emerging biopharmaceutical company focused on researching and developing innovative therapies to combat the aging process and related diseases. The company was founded in 2017 by Michael D. West, one of the most renowned pioneers in the field of regenerative medicine and stem cell research. AgeX Therapeutics' business model is based on utilizing groundbreaking knowledge in regenerative medicine, genomics, and cryobiology to develop new treatment methods that enable longer lifespan and higher quality of life. The company has developed a wide range of products and services focused on tissue and organ regeneration and repair. One of AgeX Therapeutics' main branches is the development of human embryonic stem cells (hES cells), which can be used as starting material for the production of cells and tissues. These cells have the potential to transform into any type of cell or tissue, making them a revolutionary tool in regenerative medicine. AgeX Therapeutics works closely with other companies and research institutions to further improve its hES cell technology and find new ways to implement it in practical applications. Another important area of AgeX Therapeutics is targeted genome editing, a procedure for modifying the genetic material of cells and organisms. This procedure can be used to correct genetic defects, treat diseases, or slow down the aging process. AgeX Therapeutics has developed its own technology platform to make targeted genome editing procedures more efficient and precise. AgeX Therapeutics' products and services also include bioelectric medicine, targeted senescence induction, and cryobiological storage. Bioelectric medicine utilizes electrical currents to promote tissue regeneration, while targeted senescence induction aims to selectively kill aging cells, thus slowing down the aging process. Cryobiological storage is a method for long-term storage of biological materials at extremely low temperatures to protect them from degradation and degeneration. AgeX Therapeutics is an ambitious company striving to expand the boundaries of regenerative medicine and discover new therapy options that improve people's quality of life. The company is financially stable and has a highly qualified team of scientists and medical professionals dedicated to achieving these goals. With its sophisticated technology platform and wide range of products and services, AgeX Therapeutics is well positioned to succeed in the rapidly growing market of regenerative medicine. AgeX Therapeutics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about AgeX Therapeutics Stock

How much dividend does AgeX Therapeutics pay?

Over the past 12 months, AgeX Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AgeX Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of AgeX Therapeutics?

The current dividend yield of AgeX Therapeutics is .

When does AgeX Therapeutics pay dividends?

AgeX Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AgeX Therapeutics?

AgeX Therapeutics paid dividends every year for the past 0 years.

What is the dividend of AgeX Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AgeX Therapeutics located?

AgeX Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von AgeX Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AgeX Therapeutics from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.

When did AgeX Therapeutics pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of AgeX Therapeutics in the year 2023?

In the year 2023, AgeX Therapeutics distributed 0 USD as dividends.

In which currency does AgeX Therapeutics pay out the dividend?

The dividends of AgeX Therapeutics are distributed in USD.

Andere Kennzahlen von AgeX Therapeutics

Our stock analysis for AgeX Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AgeX Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.